Termination Letter for February 27, 2012 Equity Purchase Agreement between Entest BioMedical, Inc. and Southridge Partners II, LP

Contract Categories: Business Operations › Termination Agreements
Summary

Entest BioMedical, Inc. has formally notified Southridge Partners II, LP that it is terminating their Equity Purchase Agreement, originally signed on February 27, 2012. The termination is effective as of June 1, 2012. This letter serves as the official written notice of termination between the two parties.

Read More Arrow
EX-10.28 14 entb_ex1028.htm TERMINATION LETTER FEBRUARY 27 EQUITY PURCHASE AGREEMENT ex10.28


Exhibit 10.28



Mr. Steve Hicks

SOUTHRIDGE PARTNERS II, LP

90 Grove Street

Ridgefield, Connecticut 06877


June 1, 2012



Dear Steve,


This communication is intended to provide written notice to SOUTHRIDGE PARTNERS II, LP that ENTEST BIOMEDICAL, INC. is terminating, effective June 1, 2012, the EQUITY PURCHASE AGREEMENT entered into as of the 27th day of February, 2012 by and between SOUTHRIDGE PARTNERS II, LP, Delaware limited partnership, and ENTEST BIOMEDICAL, INC., a Nevada corporation.


Sincerely,


/s/David Koos

David Koos

Chairman and CEO